Gustav A. Christensen is a businessperson who has been at the helm of 5 different companies. Mr. Christensen occupies the position of Chairman for Morphic Holding, Inc., Chairman at Morphic Therapeutic, Inc. (a subsidiary of Morphic Holding, Inc.) and President, Treasurer & Director at Phytera, Inc.

He is also on the board of Generation Bio Co.

In the past Gustav A. Christensen occupied the position of Chairman of Alpha-Beta Technology, Inc., General Manager for Baxter International, Inc., President at ImmuLogic Pharmaceutical Corp., Managing Director at Apeiron Partners LLC, Advisor at BioVentures Investors, President, Chief Executive Officer & Director at Dyax Corp., Vice President-Business Development of Genetics Institute LLC and Director at Alantos Pharmaceuticals AG.

Mr. Christensen received a graduate degree from the University of Aarhus and an MBA from Harvard Business School.